LPL Financial’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
LPL Financial's PBYI Position: Q3 2026 in Review
LPL Financial reduced its Puma Biotechnology (PBYI) stake by 8.4% in Q3 2026, selling an estimated $25.5K and leaving 31,638 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #5488.
LPL Financial first reported a position in PBYI in Q3 2021 and has held it in 13 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- LPL Financial held 31,638 shares of Puma Biotechnology worth $314K as of Q3 2026.
- LPL Financial sold 2,899 Puma Biotechnology shares in Q3 2026, an estimated $25.5K.
- Puma Biotechnology made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5488 holding.
- LPL Financial first reported a position in Puma Biotechnology in Q3 2021 and has held it in 13 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.